Proteins

Items 171-180 of 424

per page
Set Descending Direction
  1. Clusterin (secretory form) (human) (rec.)
    AG-40A-0050Y
    AG-40A-0050Y-C01010 µg
    CHF 190.00
    AG-40A-0050Y-C05050 µg
    CHF 380.00
    After denaturation of recombinant secretory clusterin in the presense of β-mercaptoethanol followed by boiling, two distinct bands, 60kDa and 35kDa, were seperated on SDS-PAGE. The two bands were extracted and subjected to determination of their N-te
  2. Contactin-6 (human):Fc (human) (rec.)
    AG-40A-0156
    AG-40A-0156-C01010 µg
    CHF 215.00
    AG-40A-0156-C05050 µg
    CHF 540.00
    Induction of Hes-1 with the treatment of hContactin-6-Fc.
A mouse preadpipocyte cell line, 3T3L1, was stimulated with 5μg/ml of hContactin-6-Fc (Prod. No. AG-40A-0156) as in indicated time points and each cell lysate was prepared and subjected to
  3. CREB-binding Protein (mouse) (rec.) (His) (highly active)
    AG-40T-0016
    AG-40T-0016-C0022 µg
    CHF 290.00
  4. CTHRC1 (human) (rec.)
    AG-40B-0157
    AG-40B-0157-C01010 µg
    CHF 335.00
    AG-40B-0157-30103 x 10 µg
    CHF 670.00
  5. CTHRC1 (mouse) (rec.)
    AG-40B-0154
    AG-40B-0154-C01010 µg
    CHF 350.00
    AG-40B-0154-30103 x 10 µg
    CHF 695.00
  6. DcR3 (human):Fc (human) (rec.)
    CHI-HF-210DcR3
    CHI-HF-210DcR3-C100100 µg
    CHF 460.00
  7. DDX3 (human) (rec.) (active) (1000µg)
    BBL-2253
    BBL-2253-M0011 mg
    CHF 6'041.00
    DDX3 (human) (rec.) (active) (1000µg)
  8. DDX3 (human) (rec.) (active) (100µg)
    BBL-2252
    BBL-2252-C100100 µg
    CHF 1'809.00
    DDX3 (human) (rec.) (active) (100µg)
  9. DDX3 (human) (rec.) (active) (10µg)
    BBL-2251
    BBL-2251-C01010 µg
    CHF 600.00
    DDX3 (human) (rec.) (active) (10µg)
  10. Dermcidin-1L (human) . TFA
    CAS  478898-18-9
    AG-CP3-0039
    AG-CP3-0039-M0011 mg
    CHF 180.00
    AG-CP3-0039-M0055 mg
    CHF 540.00
    Dermcidin-1L (human) . TFA

Items 171-180 of 424

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.